Catalio Capital
Status
ACTIVE
Global HQ
Atlanta, United States
Countries of investment
- France
- Sweden
- Saudi Arabia
Investment stages
- Pre-Seed
- Seed
- Series A
- Series B
Industries
- Logistics
- Shipping
- Transport
- -
About
Catalio Capital Management is a multistrategy investment firm focused on breakthrough biomedical technologies and innovative healthcare companies. Founded in 2020, Catalio collaborates with worldrenowned scientists and clinicians to build and grow companies that are defining the future of life sciences.
Catalio Capital Management is a multistrategy investment firm focused on breakthrough biomedical technologies and innovative healthcare companies. Founded in 2020, Catalio collaborates with worldrenowned scientists and clinicians to build and grow companies that are defining the future of life sciences.
Investment Thesis
Catalio‚„s investment thesis revolves around backing companies that are developing cutting edge drugs, devices, diagnostics, and data driven healthcare solutions. Their Nexus private Equity strategy focuses on early to late stage biomedical companies, with a commitment to working closely with founders, building strong management teams, and partnering with toptier coinvestors.
Portfolio
Alentis Therapeutics
PrognomiQ
Orasis Pharmaceuticals
Superluminal Medicines
Noetik
Elektrofi
Imperative Care
InSightec
Avava